Aug 4, 2026 07:00AM
Jul 28, 2026 07:00AM
Jun 4, 2026 08:00AM
May 29, 2026 04:01PM
May 12, 2026 07:05AM
May 12, 2026 07:01AM
May 12, 2026 07:00AM Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
May 12, 2026 07:00AM
May 5, 2026 07:00AM
May 1, 2026 03:39PM
May 1, 2026 01:12PM
May 1, 2026 12:43PM
May 1, 2026 12:43PM
Feb 24, 2026 07:00AM Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Dec 21, 2025 04:00AM
Nov 24, 2025 07:02AM
Nov 24, 2025 07:00AM
Nov 5, 2025 07:00AM
Oct 20, 2025 04:15AM
Oct 13, 2025 07:00AM
Sep 24, 2025 02:35AM BofA Securities Downgrades Arvinas Inc. (ARVN) to Neutral
Sep 19, 2025 04:47AM
Sep 17, 2025 04:31PM
Sep 17, 2025 04:30PM
Aug 8, 2025 04:05PM
Aug 8, 2025 04:05PM
Aug 6, 2025 07:00AM
Jun 11, 2025 08:30AM Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
Jun 6, 2025 08:38AM
Jun 6, 2025 07:01AM
Jun 6, 2025 07:00AM
May 31, 2025 08:00AM
May 31, 2025 08:00AM
May 1, 2025 07:00AM
Apr 23, 2025 10:45AM Arvinas (ARVN) Announces Results from the VERITAC-2 Trial Selected as Late-Breaking Oral Presentation at the 2025 American Society of Clinical Oncology
Apr 23, 2025 10:44AM
Apr 9, 2025 09:34AM
Mar 11, 2025 06:46AM
Mar 11, 2025 06:45AM
Feb 11, 2025 07:00AM
Jan 10, 2025 07:08AM
Jan 10, 2025 07:00AM Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, Highlights Upcoming Milestones, and Provides Corporate Update
Dec 22, 2024 04:00AM
Dec 10, 2024 09:09AM
Dec 10, 2024 09:05AM
Nov 25, 2024 05:35PM
Oct 30, 2024 07:00AM
Jul 30, 2024 07:00AM
Jul 22, 2024 08:31AM HOOKIPA Pharma Inc. (HOOK) Announces Leadership Changes to Intensify Focus on HB-200
Jul 22, 2024 08:30AM

327,748 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All